Great Lakes Advisors’s Agilon Health AGL Stock Holding History

Great Lakes Advisors’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$702K	Buy	+6,549	New	+$429K	0.01%	571

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Great Lakes Advisors's AGL Position: Q2 2026 in Review

Great Lakes Advisors opened a new position in Agilon Health (AGL) in Q2 2026: 6,549 shares worth $702K. The stake represents 0.01% of the portfolio and ranks #571 among its holdings.

179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Great Lakes Advisors held 6,549 shares of Agilon Health worth $702K as of Q2 2026.
Agilon Health was a new Great Lakes Advisors position in Q2 2026.
Agilon Health made up 0.01% of Great Lakes Advisors's portfolio in Q2 2026, its #571 holding.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.